ATMP Consulting Group

ATMP Consulting Group and PQP Group Announce Strategic Alliance

Gainesville, FL — ATMP Consulting Group and PQP Group are pleased to announce a collaborative and strategic alliance designed to expand the depth and breadth of expertise available to clients across advanced therapies.

Building on PQP Group’s global quality leadership and operational experience across pharmaceutical, biotechnology, and advanced therapy environments, together with ATMP Consulting Group’s deep, hands‑on expertise across the cell and gene therapy lifecycle, the alliance enables clients of both organizations to access a unified network of subject matter experts.

The combined client-centric service model enables a strong service offering and ‘deep bench’ capability for supply from internal and outsourced client models in support of all phases of clinical programs to commercialization. 

Scott Cross, Founder and CEO of ATMP Consulting Group, said “This alliance brings together experts with broad experience and expertise in bringing these very complicated medicines to the clinic and market.” “By combining PQP’s deep quality leadership with decades of advanced therapy experience, we are better positioned to support clients as they navigate increasingly complex development, manufacturing, regulatory, and commercialization challenges.”

Simon Baker, Co-Founder of PQP Group, said “Partnering with ATMP Consulting Group brings deep, hands‑on experience across cell and gene therapy development, manufacturing, and regulatory strategy, which strongly complements PQP’s established quality leadership and operational capabilities. 

With licensed operations across the UK and EU, supported by a strategic alliance in the United States, together we are well positioned to support global advanced therapy programs with integrated, practical solutions that enable innovation while maintaining robust regulatory compliance throughout the product lifecycle. 

In particular, ATMP Consulting and PQP provide a combined service offering to support both US, EU and regulatory strategy, CMC authorship, technical, Quality and supply chain solutions to enable Clinical and Commercial programs”

The collaboration reflects a shared commitment to delivering practical, high‑impact solutions and creating long‑term value for clients across the advanced therapy, biologics, and vaccine landscapes.

About ATMP Consulting Group

ATMP Consulting Group provides expert strategic and technical guidance across advanced therapies, biologics, vaccines and peripheral industries. The firm partners with clients to solve critical CMC, manufacturing, analytical and regulatory challenges from early development through commercialization.

About PQP Group

PQP Group is a consulting firm providing specialized quality, compliance, and risk-management solutions tailored for pharmaceutical, biotech, and cell and gene therapy organizations. The firm delivers quality leadership and execution support to life sciences organizations, helping clients achieve sustainable compliance and operational excellence.

PQP Group have also established regulatory licenses and authorizations for import, secondary packaging, QP release and general depot and logistic services supporting the major dosage forms, as advanced therapy products within the UK and EU.